The Contact Phase of Blood Coagulation in Diabetes Mellitus and in Patients with Vasculopathy
- 1 January 1984
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 52 (03) , 221-223
- https://doi.org/10.1055/s-0038-1661181
Abstract
The contact phase has been studied in diabetics and patients with macroangiopathy. Factor XII and high molecular weight kininogen (HMWK) are normal. C1-inhibitor and also α2-macroglobulin are significantly elevated in diabetics with complications, for α1-macroglobulin especially in patients with nephropathy, 137.5% ± 36.0 (p 1-inhibitor is also increased in vasculopathy without diabetes 113.2 ± 22.1 (p <0.01). Prekallikrein (PK) is increased in all patients’ groups (Table 2) as compared to normals. PK is particularly high (134% ± 32) in 5 diabetics without macroangiopathy but with sensomotor neuropathy. This difference is remarkable because of the older age of diabetics and the negative correlation of PK with age in normals.Keywords
This publication has 7 references indexed in Scilit:
- Fifteen Coagulation and Fibrinolysis Parameters in Diabetes Mellitus and in Patients with VasculopathyThrombosis and Haemostasis, 1984
- Prekallikrein, HMW-kininogen and factor XII in various disease statesThrombosis Research, 1983
- Plasma kallikrein activity in human diabetes mellitusMetabolism, 1983
- Contact phase of blood coagulation in diabetes mellitusEuropean Journal of Clinical Investigation, 1982
- RABBIT ANTIBODIES AGAINST THE PROCOAGULANT ACTIVITY (VIII-C) OF HUMAN FACTOR-VIII - SOME THEORETICAL AND PRACTICAL CONSIDERATIONS ON THE HUMAN FACTOR-VIII MOLECULE USING HETEROLOGOUS ANTIBODIES1981
- Amidolytic activity in normal human plasma assessed with chromogenic substancesThrombosis Research, 1979
- Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodiesAnalytical Biochemistry, 1966